Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Enhancing Tregs can protect against alopecia areata.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Targeting ornithine decarboxylase can help prevent skin cancer.

The treatment was ineffective in humans.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

A CCS patient with severe complications was successfully treated using combined therapies.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Tocilizumab might be an effective treatment for COVID-19.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Removing the Crif1 gene in mouse skin disrupts skin balance and hair growth.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.